GCK and diabetes mellitus: In rodent models of diabetes, high-dose biotin—likely via effects mediated by cGMP—acts on the liver to promote induction of glucokinase, while suppressing induction of enzymes which promote gluconeogenesis and lipogenesis [213,214,215,216,217].